Brett K Haumann's Net Worth

$11.4 Million

Estimate Recalculated Jul 12, 2024 05:17PM EST

Who is Brett K Haumann?

Brett K Haumann has an estimated net worth of $11.4 Million. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., and Aimmune Therapeutics, Inc..

SEC CIK

Brett K Haumann's CIK is 0001607733

Past Insider Trading and Trends

2020 was Brett K Haumann's most active year for acquiring shares with 4 total transactions. Brett K Haumann's most active month to acquire stocks was the month of January. 2020 was Brett K Haumann's most active year for disposing of shares, totalling 8 transactions. Brett K Haumann's most active month to dispose stocks was the month of July. 2015 saw Brett K Haumann paying a total of $0.00 for 135,000 shares, this is the most they've acquired in one year. In 2020 Brett K Haumann cashed out on 117,121 shares for a total of $2,722,059.72, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.505

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.82%
-35.67K
$18.79
-$670,276.88
242.5K
Feb 20
Form 4
-1.64%
-4.64K
$17.21
-$79,837.19
278.17K
Nov 20
Form 4
-9.49%
-29.65K
$18.28
-$541,890.12
282.81K
Aug 20 - Aug 21
Form 4
-1.33%
-4.21K
$26.67
-$112,334.04
312.46K
May 20
Form 4
-9.59%
-33.61K
$25.90
-$870,447.20
316.67K
Feb 20
Form 4
+51.45%
119K
—
—
350.28K
Feb 3
Form 4
-1.15%
-2.69K
$17.60
-$47,379.20
231.28K
Nov 20
Form 4
-1.15%
-2.71K
$21.51
-$58,292.10
233.97K
Aug 20
Form 4
-1.13%
-2.71K
$19.84
-$53,667.20
236.68K
May 20
Form 4
-3.15%
-7.78K
$27.00
-$210,006.00
239.38K
Feb 20
Form 4
+33.53%
112.25K
—
—
447.07K
Feb 5
Form 4
-5.18%
-7.37K
$24.79
-$182,652.72
134.91K
Nov 20
Form 4
-4.49%
-6.68K
$26.95
-$180,106.85
142.28K
Aug 20
Form 4
-15.34%
-26.99K
$24.31
-$656,151.21
148.96K
May 20
Form 4
+23.73%
33.75K
—
—
175.95K
May 14
Form 4
-5.51%
-8.29K
$29.09
-$241,243.37
142.2K
Feb 20
Form 4
+6.36%
9K
—
—
150.5K
Feb 12
Form 4
-5.25%
-7.85K
$28.58
-$224,238.68
141.5K
Nov 20
Form 4
-4.52%
-7.06K
$27.40
-$193,553.60
149.34K
Aug 20
Form 4
-4.32%
-7.07K
$36.83
-$260,203.95
156.41K
May 20
Form 4
-7.89%
-14.00K
$31.50
-$440,974.72
163.47K
Mar 6 - Mar 7
Form 4
-7.52%
-14.43K
$33.78
-$487,580.52
177.47K
Feb 20
Form 4
+4.92%
9K
—
—
191.91K
Feb 6
Form 4
-2.86%
-5.39K
$31.96
-$172,200.48
182.91K
Nov 20
Form 4
-2.33%
-4.49K
$27.99
-$125,703.09
188.29K
Aug 25
Form 4
-6.82%
-14.12K
$27.94
-$394,455.96
192.78K
Aug 19 - Aug 20
Form 4
-2.18%
-4.61K
$20.55
-$94,694.40
206.9K
May 20
Form 4
+74.07%
90K
—
—
211.51K
Mar 15
Form 4
-13.17%
-18.43K
$15.65
-$288,351.25
121.51K
Feb 20
Form 4
-0.56%
-781.00
$17.17
-$13,409.77
139.93K
Nov 20
Form 4
+2,362.62%
135K
—
—
140.71K
Feb 5
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

Aimmune Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-19.56K
$34.50
-$674,923.50
0
Oct 10 - Oct 13
Form 4
+213.01%
13.31K
—
—
19.56K
May 27
Form 3
—
0
—
—
0
No matching records found